Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pharmaceutical composition for treating vitreous opacity

A vitreous turbidity and composition technology, which is applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of insignificant drug efficacy, vitrectomy cost, unstable efficacy, and unsatisfactory treatment effect, etc.

Inactive Publication Date: 2017-05-17
JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the effect of drugs is not significant, and the cost and curative effect of vitrectomy are also unstable. Therefore, the effect of traditional vitreous opacity treatment is not very satisfactory.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating vitreous opacity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 1: Pharmaceutical composition for treating vitreous opacity and its preparation method

[0038] The composition and weight parts of the raw material medicine of the pharmaceutical composition for treating vitreous opacity are: eucalyptus fruit 4785g, a column of incense 2660g, helexin 33g, liquiritigenin C 24g, saikosaponin C18g;

[0039] Preparation:

[0040] (1) Get eucalyptus fruit, incense sticks, helexin, liquiritigenin C, saikosaponin C according to the raw material drug ratio, mix well, use 26% ethanol by weight as a solvent, and extract by warm soaking at 28°C , the extraction times are 7 times, the extraction time is 12 hours each time, and the amount of solvent each time is 60 times the total weight of the raw material, filtered to obtain medicinal residues A and extract A, extract A recovers ethanol, and concentrates to relative density 1.07, filtered, the medicinal liquid was passed through the XAD-16 macroporous adsorption resin column, first elute...

Embodiment 2

[0043] Example 2: Pharmaceutical composition for treating vitreous opacity and its preparation method

[0044] The composition and weight parts of the raw material medicine of the pharmaceutical composition for treating vitreous opacity are: 4780g eucalyptus fruit, 2670g incense sticks, 30g hederagenin, 26g liquiritigenin C, 17g saikosaponin;

[0045] Preparation:

[0046] (1) Get eucalyptus fruit, incense sticks, helexin, liquiritigenin C, saikosaponin C according to the raw material drug ratio, mix well, use 26% ethanol by weight as a solvent, and extract by warm soaking at 28°C , the extraction times are 7 times, the extraction time is 12 hours each time, and the amount of solvent each time is 60 times the total weight of the raw material, filtered to obtain medicinal residues A and extract A, extract A recovers ethanol, and concentrates to relative density 1.07, filtered, the medicinal liquid was passed through the XAD-16 macroporous adsorption resin column, first eluted ...

Embodiment 3

[0049] Example 3: Pharmaceutical composition for treating vitreous opacity and its preparation method

[0050] The composition and weight parts of the raw material medicine of the pharmaceutical composition for treating vitreous opacity are: eucalyptus fruit 4790g, a column of incense 2650g, helexin 36g, liquiritigenin C 22g, saikosaponin C19g;

[0051] Preparation:

[0052] (1) Get eucalyptus fruit, incense sticks, helexin, liquiritigenin C, saikosaponin C according to the raw material drug ratio, mix well, use 26% ethanol by weight as a solvent, and extract by warm soaking at 28°C , the extraction times are 7 times, the extraction time is 12 hours each time, and the amount of solvent each time is 60 times the total weight of the raw material, filtered to obtain medicinal residues A and extract A, extract A recovers ethanol, and concentrates to relative density 1.07, filtered, the medicinal liquid was passed through the XAD-16 macroporous adsorption resin column, first elute...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating vitreous opacity and a preparation method of the pharmaceutical composition. The pharmaceutical composition is prepared from the raw material medicines including eucalyptus fruits, common anotis herb, hederagenin, glepidotin C and saikoside in proportion, can be prepared into various dose forms by virtue of conventional preparation processes and has a remarkable effect to the treatment of the vitreous opacity.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a pharmaceutical composition for treating vitreous opacity and a preparation method thereof. Background technique [0002] Vitreous opacity refers to the vitreous opacity that is dusty, filamentous, flocculent, streak-like, and cloud-like, and the patient can see black shadows of different shapes flying and drifting in front of the eyes. It is not an independent eye disease, but a common manifestation of many eye diseases, so it is often ignored by people. However, as one of the common clinical signs of ophthalmology, patients often perceive that their vision has different degrees of obstruction and discomfort. Severe vitreous opacity can lead to blindness. Because the vitreous itself has neither blood vessels nor nerve tissue, the metabolism is extremely slow, so when the vitreous is cloudy, the curative effect is often poor. Vitreous opacity ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/74A61P27/02A61K31/56A61K31/353A61K31/7048
CPCA61K36/74A61K31/353A61K31/56A61K31/7048A61K36/61A61K2236/333A61K2236/39A61K2236/51A61K2236/55
Inventor 不公告发明人
Owner JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com